可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Coletta J,Suzuki N,Nascimento BR,et al.Use of optical coherence tomography for accurate characterization of atherosclerosis[J].Arq Bras Cardiol,2010,94(2):250-259,268-272.
[2]Li BH,Leung AS,Soong A,et al.Hybrid intravascular ultrasound and optical coherence tomography catheter for imaging of coronary atherosclerosis[J].Catheter Cardiovasc Interv,2013,81(3):494-507.
[3]Hong MK,Mintz GS,Lee CW,et al.Plaque ruptures in stable angina pectoris compared with acute coronary syndrome[J].Int J Cardiol,2007,114(2):7882.
[4]Mann JM,Davies MJ.Vulnerable plaque.Relation of characteristics to degree of stenosis in human coronary arteries[J].Circulation, 1996,94(5):928-931.
[5]Jang IK,Tearney GJ,MacNeill B,et al.In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography[J].Circulation,2005,111(12):1551-1555.
[6]Naghavi M,Libby P,Falk E,et al.From vulnerable plaque to vulnerable patient:a call for new definitions and risk assessment strategies:Part II[J].Circulation,2003,108(15):1772-1778.
[7]Miyamoto Y,Okura H,Kume T,et al.Plaque characteristics of thincap fibroatheroma evaluated by OCT and IVUS[J].JACC Cardiovasc Imaging,2011,4(6):638-646.
[8]Jang IK,Tearney G,Bouma B.Visualization of tissue prolapse between coronary stent struts by optical coherence tomography:comparison with intravascular ultrasound[J].Circulation,2001,104(22):2754.
[9]Bea F,Blessing E,Bennett B,et al.Simvastatin promotes atherosclerotic plaque stability in apoE-deficient mice independently of lipid lowering[J].Arterioscler Thromb Vasc Biol,2002,22(11):1832-1837.
[10]Zaman AG,Helft G,Worthley SG,et al.The role of plaque rupture and thrombosis in coronary artery disease[J].Atherosclerosis,2000,149(2):251-266.
[11]Kubo T,Imanishi T,Takarada S,et al.Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy[J].J Am Coll Cardiol,2007,50(10):933-939.